GO and KEGG pathway enrichment analyses further confirmed that key biological processes involved in high SLC2A1 expressing cells may be closely linked to tumor energy metabolism and cell proliferation (Fig. 12D, E). The gene discussed is SLC2A1; the disease is neoplasm.